SOUTH KOREA —Celltrion and Genuv, two Korean companies, have entered into a joint agreement for research and development with the potential to earn a nine-figure sum. The partnership aims to…
Read MoreDay: 14 March 2023
Egypt supports Ghana’s fight against Hepatitis C with 50,000 medicines
GHANA – Ghana has received 50,000 anti-Hepatitis C medicines from the Egyptian government to support the ongoing fight against Hepatitis C in the country. The intervention is under the Screening…
Read MoreUCB and Eli Lilly lead US$52M funding round for innovative RNA Biotech startup
USA — Belgian biopharmaceutical company UCB and American pharmaceutical giant Eli Lilly have led a US$52 million funding round for RNA biotech startup Switch Therapeutics for its conditionally activated siRNA…
Read MoreHIV infection decline by 2% in Tanzania’s coast region
TANZANIA – Funded by the Centre for Diseases Control and Prevention (CDC) and implemented jointly by the government and Tanzania Health Promotion Services (THPS), Afya Hatua Project has enhanced quality…
Read MoreMerck appeals EMA’s decision to reject Covid-19 antiviral drug
NETHERLANDS — Merck is appealing the EMA’s rejection of its Covid-19 pill, Lagevrio, which serves as an alternative to Pfizer’s Paxlovid. The EMA stated that they couldn’t conclude that Lagevrio…
Read MoreUS NIH grants Frank Tanser US$2.2m to design future HIV-prevention strategies
SOUTH AFRICA – The US National Institutes of Health has granted Frank Tanser, a leading scientist in HIV research based at Stellenbosch University, R40 million (US$2.21m) for over five years…
Read MorePfizer, Biovac launch freezer farm facility for vaccine storage and supply
SOUTH AFRICA – Pfizer and Biovac have launched a freezer farm facility which will serve as an ultracold storage facility and add to the institute’s capacity for vaccine storage and…
Read MoreSanofi to expand portfolio with US$2.9bn acquisition of Provention Bio
FRANCE — French drugmaker Sanofi has agreed to acquire US-based pharmaceutical firm Provention Bio for approximately US$2.9 billion to strengthen its general medicines portfolio with the US-approved type 1 diabetes…
Read MorePfizer’s Zavzpret nasal spray granted FDA approval for migraine treatment
USA — The U.S. Food and Drug Administration (FDA) has approved Pfizer’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. As the first…
Read MoreSohar International extends partnership with Athar Foundation on healthcare delivery in Oman
OMAN – Sohar International Bank and the Health Endowment Foundation (Athar) have expanded their collaboration to advance the healthcare system across the Sultanate of Oman. Sohar International Bank, formerly Bank…
Read More